Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Gland Pharma: What Should You Do?
Gland pharma is primarily a generic injectables manufacturing and CDMO (Contract Development and Manufacturing Outsourcing) company. Its growth will be driven by base operations and recovery in acquired operations. The company has established a…
Candriam S.C.A. Acquires 43,338 Shares of Ascendis Pharma A/S $ASND
Candriam S.C.A. grew its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 23.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned…
Hsbc Holdings PLC Lowers Stock Holdings in Royalty Pharma PLC $RPRX
Hsbc Holdings PLC cut its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 75.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,998…
World Investment Advisors Sells 48,485 Shares of Royalty Pharma PLC $RPRX
World Investment Advisors lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 83.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.
Royalty Pharma PLC $RPRX is Torray Investment Partners LLC's Largest Position
Torray Investment Partners LLC trimmed its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 13.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 645,425…
Health Care Down on Rotation Back to Tech - Health Care Roundup
Health-care companies fell as traders rotated back into risky sectors. The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. Shares of obesity drug…
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Vivani Medical believes a tiny implant placed under the skin could help address the biggest issue with blockbuster GLP-1s: keeping patients on treatment to maintain their weight loss. The biotech company is in the early stages of developing an…
Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA
The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. The agency greenlit Merck's Keytruda and its subcutaneous formulation Keytruda QLEX, together…
/afaqs/media/media_files/2026/07/11/jiostar-2026-07-11-11-07-08.jpg)
Former JioStar executive Vishal Sharma joins J Brrothers as India head
US-based J Brrothers LLC has appointed Vishal N. Sharma as head of India operations. In the new role, he will oversee the company's operations in India and support its global expansion plans. Sharma joins the company after a seven-year stint at…
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?
AstraZeneca posted a rare clinical trial failure on Thursday, sending shares down 6% to their worst day in over two years. Analysts estimate the trial miss wiped just 2-4% from their valuation models but the market reaction suggested it was about…
ARMOUR Residential REIT: A High Yield But Volatile Idea For Income Investors (NYSE:ARR)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
ED Visits Often Precede Cancer; Shrinking Radiation Access; Beware 'Free' Drug Plans
A study of national insurance claims data showed that a fourth of patients with newly diagnosed cancers had a recent emergency department (ED) visit that resulted in nonspecific findings. (Trilliant Health) Accord BioPharma announced FDA approval…
Stocks rise as investors await the start of earnings season - here's what to expect
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks are slightly higher on Friday. The S & P 500 is on track to…
Simply Put: FDA Inspections
Leo and Emraan meet in the office cafeteria over a cup of coffee, and the discussion moves from football to US FDA at a surprising pace. Leo: Hey, did you see the match yesterday? Argentina won like I said. Emraan: The player made a foul and should…
Should You Buy Eli Lilly Stock? Here's My Honest Take.
Eli Lilly (LLY 2.30%) is in a league of its own. It's the largest healthcare company in the world by market cap, with the No. 2 company (Johnson & Johnson (JNJ 0.82%)) barely over half as big. Lilly's shares have more than quintupled in value over…
Receive a Daily briefing on Pharma Industry News
Get Started